Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Avelumab vs Docetaxel for Previously Treated Advanced NSCLC: Primary Analysis of the Phase 3 JAVELIN Lung 200 Trial
- Authors
- Barlesi, F[Barlesi, F.]; Vansteenkiste, J[Vansteenkiste, J.]; Spigel, D[Spigel, D.]; Ishii, H[Ishii, H.]; Garassino, M[Garassino, M.]; De Marinis, F[De Marinis, F.]; Ozguroglu, M[Ozguroglu, M.]; Szczesna, A[Szczesna, A.]; Polychronis, A[Polychronis, A.]; Uslu, R[Uslu, R.]; Krzakowski, M[Krzakowski, M.]; Lee, J[Lee, J.]; Calabro, L[Calabro, L.]; Frontera, O[Frontera, O.]; Ellers-Lenz, B[Ellers-Lenz, B.]; Bajars, M[Bajars, M.]; Ruisi, M[Ruisi, M.]; Parki, K[Parki, K.]
- Issue Date
- Oct-2018
- Publisher
- ELSEVIER SCIENCE INC
- Keywords
- Phase 3; avelumab; docetaxel
- Citation
- JOURNAL OF THORACIC ONCOLOGY, v.13, no.10, pp.S331 - S332
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF THORACIC ONCOLOGY
- Volume
- 13
- Number
- 10
- Start Page
- S331
- End Page
- S332
- ISSN
- 1556-0864
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.